#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	18156	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2047	878.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1391	1391	C	1042	C	972	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	18156	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2047	878.7	0	HET	.	.	.	C451T	.	451	451	C	658	658	C	1059	C,T	768,213	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32620	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3595	904.5	0	.	n	.	0	T695C	SNP	695	695	T	1020	1020	C	982	C	920	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32620	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3595	904.5	0	.	n	.	0	A1638G	SNP	1638	1638	A	1963	1963	G	1037	G,A	483,495	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32620	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3595	904.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2296	2296	C	1014	C,T,G	936,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32620	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3595	904.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2370	2370	A	997	A,T	935,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32620	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3595	904.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2922	2922	C	999	C	931	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32620	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3595	904.5	0	HET	.	.	.	C933T,A	.	933	933	C	1258	1258	C	1039	C,T,A	715,237,1	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2508	folP	855	855	100.0	folP.l15.c4.ctg.1	1537	162.3	1	SNP	p	R229S	1	.	.	685	687	AGC	987	989	AGC	243;242;242	A,G;G;C	223,1;220;218	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6484	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3451	187.6	1	SNP	p	S91F	1	.	.	271	273	TTC	654	656	TTC	210;211;209	T;T;C	196;197;192	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6484	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3451	187.6	1	SNP	p	G95N	0	.	.	283	285	GGC	666	668	GGC	217;215;214	G;G;C	197;194;197	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6484	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3451	187.6	1	SNP	p	D95G	1	.	.	283	285	GGC	666	668	GGC	217;215;214	G;G;C	197;194;197	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	2004	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1251	158.8	1	SNP	p	G45D	0	.	.	133	135	GGC	375	377	GGC	263;264;265	G;G;C	240;239;246	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1012	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	947	106.0	0	.	n	.	0	A197.	DEL	197	197	A	533	533	A	253	A	232	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6690	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2879	231.1	1	SNP	p	D86N	0	.	.	256	258	GAC	576	578	GAC	249;247;244	G,T;A;C	233,1;228;233	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6690	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2879	231.1	1	SNP	p	R87W	0	.	.	259	261	CGT	579	581	CGT	244;245;244	C;G;T	235;234;232	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6690	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2879	231.1	1	SNP	p	S87R	1	.	.	259	261	CGT	579	581	CGT	244;245;244	C;G;T	235;234;232	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6690	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2879	231.1	1	SNP	p	R87I	0	.	.	259	261	CGT	579	581	CGT	244;245;244	C;G;T	235;234;232	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6690	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2879	231.1	1	SNP	p	S88P	0	.	.	262	264	TCC	582	584	TCC	243;246;250	T;C;C	232;235;241	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5244	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2667	195.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1501	1503	GGC	282;278;271	G;G;C	259;252;247	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4934	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2400	204.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1248	1250	GCC	252;255;259	G,C;C;C,A	234,1;237;239,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4934	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2400	204.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1251	1253	ATG	258;256;256	A;T;G	239;239;235	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4934	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2400	204.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1263	1265	ACC	244;247;246	A;C;C	227;228;228	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4934	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2400	204.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1263	1265	ACC	244;247;246	A;C;C	227;228;228	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4934	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2400	204.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1764	1766	ACC	258;259;259	A;C;C	227;236;238	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4934	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2400	204.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1818	1820	GCG	247;248;247	G;C;G	223;227;224	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4934	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2400	204.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1818	1820	GCG	247;248;247	G;C;G	223;227;224	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4934	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2400	204.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1941	1943	GGT	223;220;221	G;G;T	201;202;203	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4934	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2400	204.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1950	1952	AGC	213;212;214	A;G;C	189;192;195	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4934	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2400	204.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1968	1970	CCG	197;197;199	C,CGG;C,G;G	146,1;150,2;151	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	7144	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3218	221.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1687	1689	CCG	243;243;249	C;C;G	212;216;215	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3156	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1693	184.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	530	530	C	228	C	209	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3328	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1618	204.2	0	.	p	.	0	I45V	NONSYN	133	135	ATT	467	469	GTT	274;276;277	G;T;T,C	256;253;256,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3328	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1618	204.2	1	SNP	p	G120K	1	.	.	358	360	AAG	692	694	AAG	277;280;282	A;A;G	258;263;256	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3328	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1618	204.2	1	SNP	p	A121N	1	.	.	361	363	AAC	695	697	AAC	287;287;291	A;A;C	267;269;271	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3328	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1618	204.2	1	SNP	p	N121D	0	.	.	361	363	AAC	695	697	AAC	287;287;291	A;A;C	267;269;271	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12750	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4887	260.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1438	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1035	137.7	1	SNP	p	V57M	1	.	.	169	171	ATG	458	460	ATG	306;307;309	A;T;G	285;287;288	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
